Concepedia

DONALD R. GUSTAVSON

DR

Statistics

Publications

7

Citations

323

H-Index

7

Active since

1991

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

Instytut Farmaceutyczny

Cancer Research Center

DONALD R. GUSTAVSON is an author at Bristol-Myers Squibb (United States) specializing in life sciences, microbiology, and fermentation microbiology.

Publications per year

1991–2003

7

Publications

7

Nocathiacins, New Thiazolyl Peptide Antibiotics from Nocardia sp. I. Taxonomy, Fermentation and Biological Activities.

Wenying Li, John E. Leet, HELEN A. AX et al. · The Journal of Antibiotics · 2003 · 122 citations · Full text

, , +14

Kedarcidin, a new chromoprotein antitumor antibiotic. I, Taxonomy of producing organism, fermentation and biological activity.

Kin S. Lam, GRACE A. HESLER, DONALD R. GUSTAVSON et al. · The Journal of Antibiotics · 1991 · 74 citations · Full text

, , +14

Orevactaene,1 a novel binding inhibitor of HIV-1 rev protein to Rev response element (RRE) from Epicoccum nigrum WC47880

Yue‐Zhong Shu, Qingmei Ye, Hui Li et al. · Bioorganic & Medicinal Chemistry Letters · 1997 · 49 citations

, , +13

Pyrrolosporin A, a New Antitumor Antibiotic from Micromonospora sp. C39217-R109-7. I. Taxonomy of Producing Organism, Fermentation and Biological Activity.

Kin S. Lam, GRACE A. HESLER, DONALD R. GUSTAVSON et al. · The Journal of Antibiotics · 1996 · 25 citations · Full text

, , +15

Ascosteroside, a New Antifungal Agent from Ascotricha amphitricha. I. Taxonomy, Fermentation and Biological Activities.

Jessica A. Gorman, Liping Chang, Junius M. Clark et al. · The Journal of Antibiotics · 1996 · 23 citations · Full text

, , +15

1–5 of 7